SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Elevated View Of Pink Piggybank And Blue Arrow Signs Showing Various Direction
Mergers & acquisitions
Theratechnologies in Talks with Anonymous Potential Buyer While Fielding Future Pak Buyout Offer
Future Pak—whose acquisition offer was rejected by Vanda Pharmaceuticals last summer—is offering to buy Theratechnologies for an unsolicited $255 million. The Canadian biotech is under an exclusivity agreement with another yet-to-be-disclosed potential purchaser.
April 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Robert F. Kennedy Jr. is sworn in as Secretary of the Department of Health and Human Services at the White House, Thursday, February 13, 2025. (Official White House Photo by Joyce Boghosian.)
Government
HHS Secretary Kennedy Accuses FDA Employees of Being Industry ‘Sock Puppet’
Leerink analysts warned that Kennedy’s remarks to FDA staff would likely be a negative for the biotech industry.
April 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Genetically engineered chimeric antigen receptor immune cell with implanted mrna gene strand - 3d illustration
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
 · 
6 min read
 · 
BioSpace Insights
A 3D rendering depicts an antibody molecule floating above robotic hands against a white backdrop.
Machine Learning
Opinion: Smart Antibodies Will Transform Our Fight Against Solid Tumors
AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing healthy tissues.
April 14, 2025
 · 
4 min read
 · 
Gino Van Heeke
American Flag Umbrella Standing Out in the Rain Among Dark Umbrellas
FDA
FDA After the Storm: Drug Review Delays and Increased Executive Oversight Expected
After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with regulatory experts predicting delays in drug approvals and greater influence of political appointees.
April 14, 2025
 · 
6 min read
 · 
Heather McKenzie
A scientist with pill bottles in front of FDA headquarters
FDA
FDA Action Alert: Regeneron, Sanofi and Abeona
Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for Regeneron, one with partner Sanofi.
April 14, 2025
 · 
3 min read
 · 
Tristan Manalac
Crowd of people on United States map with American flag design.
Editorial
Biopharma Professionals Know All Too Well What Laid-Off HHS Employees Are Experiencing
Health and Human Services employees aren’t the only ones out of work. Thousands of private-sector biopharma professionals lost their jobs in the first quarter.
April 11, 2025
 · 
2 min read
 · 
Angela Gabriel
Contemporary halftone collage. Concept of mobile apps and services, online communication, social media,rating.Business creative illustrat. Vector illustration
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
 · 
3 min read
 · 
BioSpace Editorial Staff
US Capitol_Andrea Izzotti_Adobe Stock
Government
Lawmakers Seek to Boost US Biotech Sector, Keep China’s Growth in Check
According to analysts at Jefferies, legislation such as the newly proposed bills that aim to streamline regulatory processes would be a positive for the biotech industry.
April 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS